(SLE)
AXATILIMAB(INNC)
IMMUNOGLOBULIN G4-KAPPA, ANTI-[HOMO SAPIENS CSF1R (COLONY STIMULATING FACTOR 1 RECEPTOR, CSF-1R, CSF-1-R, MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR, C-FMS, FMS, CD115)], HUMANIZED MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HUMANIZED (1-453) [VH (HOMO SAPIENS IGHV2-70*11 (89.9%) -(IGHD) -IGHJ3*01 (92.9%)) [10.7.18] (1-126) -HOMO SAPIENS IGHG4*01 (CH1 (127-224), HINGE S10>P (234)(225-236), CH2 (237-346), CH3 (347-451), CHS (452-453)) (127-443)], (140-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') [V-KAPPA (HOMO SAPIENS IGKV1-6*01 (87.2%) -IGKJ4*01 (100.0%)) [6.3.9] (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')]; DIMER (232-232'':235-235'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) DG44 CELL LINE, GLYCOFORM ALFA. PROPOSED INN LIST 121(WHOM)
AXATILIMABUM(INN)